Literature DB >> 32902815

FAT1 biallelic truncating mutation causes a non-syndromic proteinuria in a child.

Rini Rossanti1, Toshio Watanabe2, China Nagano3, Shigeo Hara4, Tomoko Horinouchi3, Tomohiko Yamamura3, Nana Sakakibara3, Takeshi Ninchoji3, Kazumoto Iijima3, Kandai Nozu3.   

Abstract

The identification of monogenic causes in patients with proteinuria has revealed that the encoded proteins functionally participate in distinct cellular tasks and signaling pathways in the slit diaphragms of the glomerular basement membrane. FAT1 is a member of a small family of vertebrate-cadherin-like genes, which is a crucial component in slit diaphragms and has a vital role in tubular regeneration. Only 5 cases with glomerulonephritis having FAT1 gene biallelic variants have been reported. However, only one had the biallelic truncating variant, and others had missense variants. Therefore, we need further evidence of this gene being responsible for steroid-resistant nephrotic syndrome (SRNS) or glomerulonephritis. Here we describe a 5-year-old boy in who proteinuria was detected at the age of 3 years without any extrarenal symptom. The pathological findings were examined, and targeted exome sequencing was performed. We also conducted reviews for all previously-reported cases of glomerulonephritis possessing FAT1 biallelic gene variants. We found two novel truncating variants in FAT1 (NM_005245.3), c.12867dup in exon 10, and, c.5480_5483del in exon 25. Our case showed mild proteinuria compared to previously-reported cases who showed SRNS and extrarenal symptoms that might have been because the latter variant in our patient was located on out of cadherin domains; however, our follow up period is short and we further need careful follow up. Our findings corroborate the evidence that individuals with FAT1-truncating variants can show isolated mild proteinuria. Further studies are needed to investigate the genotype-phenotype correlation in this disease. Therefore, our case will provide vital information regarding this rare condition.

Entities:  

Keywords:  FAT-1 mutation; Steroid-resistant nephrotic syndrome

Year:  2020        PMID: 32902815      PMCID: PMC7829294          DOI: 10.1007/s13730-020-00529-y

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  17 in total

1.  Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney.

Authors:  Eishin Yaoita; Hidetake Kurihara; Yutaka Yoshida; Tsutomu Inoue; Asako Matsuki; Tatsuo Sakai; Tadashi Yamamoto
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

2.  FAT is a component of glomerular slit diaphragms.

Authors:  T Inoue; E Yaoita; H Kurihara; F Shimizu; T Sakai; T Kobayashi; K Ohshiro; H Kawachi; H Okada; H Suzuki; I Kihara; T Yamamoto
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

Review 3.  Hereditary proteinuria syndromes and mechanisms of proteinuria.

Authors:  Karl Tryggvason; Jaakko Patrakka; Jorma Wartiovaara
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

4.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

Authors:  Rainer G Ruf; Anne Lichtenberger; Stephanie M Karle; Johannes P Haas; Franzisco E Anacleto; Michael Schultheiss; Isabella Zalewski; Anita Imm; Eva-Maria Ruf; Bettina Mucha; Arvind Bagga; Thomas Neuhaus; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

5.  Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype.

Authors:  Lorenza Ciani; Anjla Patel; Nicholas D Allen; Charles ffrench-Constant
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

6.  Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations.

Authors:  U Lenkkeri; M Männikkö; P McCready; J Lamerdin; O Gribouval; P M Niaudet; K Antignac C; C E Kashtan; C Homberg; A Olsen; M Kestilä; K Tryggvason
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

7.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

8.  Comprehensive genetic diagnosis of Japanese patients with severe proteinuria.

Authors:  China Nagano; Tomohiko Yamamura; Tomoko Horinouchi; Yuya Aoto; Shinya Ishiko; Nana Sakakibara; Yuko Shima; Koichi Nakanishi; Hiroaki Nagase; Kazumoto Iijima; Kandai Nozu
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

Review 9.  Function and cancer genomics of FAT family genes (review).

Authors:  Masaru Katoh
Journal:  Int J Oncol       Date:  2012-10-17       Impact factor: 5.650

10.  FAT1 mutations cause a glomerulotubular nephropathy.

Authors:  Heon Yung Gee; Carolin E Sadowski; Pardeep K Aggarwal; Jonathan D Porath; Toma A Yakulov; Markus Schueler; Svjetlana Lovric; Shazia Ashraf; Daniela A Braun; Jan Halbritter; Humphrey Fang; Rannar Airik; Virginia Vega-Warner; Kyeong Jee Cho; Timothy A Chan; Luc G T Morris; Charles ffrench-Constant; Nicholas Allen; Helen McNeill; Rainer Büscher; Henriette Kyrieleis; Michael Wallot; Ariana Gaspert; Thomas Kistler; David V Milford; Moin A Saleem; Wee Teik Keng; Stephen I Alexander; Rudolph P Valentini; Christoph Licht; Jun C Teh; Radovan Bogdanovic; Ania Koziell; Agnieszka Bierzynska; Neveen A Soliman; Edgar A Otto; Richard P Lifton; Lawrence B Holzman; Nicholas E S Sibinga; Gerd Walz; Alda Tufro; Friedhelm Hildebrandt
Journal:  Nat Commun       Date:  2016-02-24       Impact factor: 14.919

View more
  2 in total

1.  Expanding the Spectrum of FAT1 Nephropathies by Novel Mutations That Affect Hippo Signaling.

Authors:  Francesca Fabretti; Nikolai Tschernoster; Florian Erger; Andrea Hedergott; Anja K Buescher; Claudia Dafinger; Bjoern Reusch; Vincent K Köntges; Stefan Kohl; Malte P Bartram; Lutz Thorsten Weber; Holger Thiele; Janine Altmueller; Bernhard Schermer; Bodo B Beck; Sandra Habbig
Journal:  Kidney Int Rep       Date:  2021-01-29

2.  Whole Exome Sequencing Is the Minimal Technological Approach in Probands Born to Consanguineous Couples.

Authors:  Francesca Peluso; Stefano Giuseppe Caraffi; Roberta Zuntini; Gabriele Trimarchi; Ivan Ivanovski; Lara Valeri; Veronica Barbieri; Maria Marinelli; Alessia Pancaldi; Nives Melli; Claudia Cesario; Emanuele Agolini; Elena Cellini; Francesca Clementina Radio; Antonella Crisafi; Manuela Napoli; Renzo Guerrini; Marco Tartaglia; Antonio Novelli; Giancarlo Gargano; Orsetta Zuffardi; Livia Garavelli
Journal:  Genes (Basel)       Date:  2021-06-24       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.